These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9168061)

  • 21. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis.
    Peretz D; Kimel N; Fujii DK; Neufeld G
    Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements.
    Hirsch HH; Nair AP; Backenstoss V; Moroni C
    J Biol Chem; 1995 Sep; 270(35):20629-35. PubMed ID: 7657642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH
    Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
    Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
    Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
    Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
    Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms.
    Wang XY; McCubrey JA
    Cell Growth Differ; 1996 Apr; 7(4):487-500. PubMed ID: 9052990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
    Schäfer R; Geisse S; Willecke K
    J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition.
    Algate PA; McCubrey JA
    Oncogene; 1993 May; 8(5):1221-32. PubMed ID: 8479745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mutationally activated Ha-ras on c-fos expression kinetics in rat tracheal epithelial cells.
    Hubbard FC; Cosma G; Garte SJ
    Mol Carcinog; 1996 Jun; 16(2):77-82. PubMed ID: 8645429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of myeloid cell growth by distinct effectors of Ras.
    Matsuguchi T; Kraft AS
    Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of interleukin 2 receptors on interleukin 3-dependent cell lines.
    Koyasu S; Yodoi J; Nikaido T; Tagaya Y; Taniguchi Y; Honjo T; Yahara I
    J Immunol; 1986 Feb; 136(3):984-7. PubMed ID: 3079807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ
    Mol Carcinog; 1999 Nov; 26(3):150-6. PubMed ID: 10559789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.
    Nair AP; Diamantis ID; Conscience JF; Kindler V; Hofer P; Moroni C
    Mol Cell Biol; 1989 Mar; 9(3):1183-90. PubMed ID: 2498644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.
    Kovnat A; Buick RN; Choo B; De Harven E; Kopelyan I; Trent JM; Tannock IF
    Cancer Res; 1988 Sep; 48(17):4993-5000. PubMed ID: 3409229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
    Tough DF; Feng X; Chow DA
    Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of oncogene mRNA sequences in cultured cells by in situ hybridization.
    Stoner GD; You M; Skouv J; Budd GC; Pansky B; Wang Y
    Ann Clin Lab Sci; 1987; 17(2):74-82. PubMed ID: 3579212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
    Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.